Personalized care in patients with metastatic cancer: cognitive, mental and physical training to empower patients with chronic cancer.

Conditions: metastatic (colorectal) cancer
metastatic disease
10017991

Registration Number: NL-OMON42828

Lead Sponsor: Radboud Universitair Medisch Centrum

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Pending

Sex: Not specified

Target Recruitment: 20

Inclusion Criteria

Patients with histologically proven metastatic (colorectal) cancer whose prognosis quad vitam is likely to be longer than 2 years.
patients that responded well to first line palliatieve treatment with chemotherapy, and opt for treatment-holiday.

Exclusion Criteria

Patients with persistent severe toxicities due to recent chemotherapy
Patients with recent (within 6 months of start of study) cardiovasculair events
Patients with severe cognitieve impairment
Patients with severe psychiatric illness

Study & Design

Study Type: Observational non invasive

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>primary study endpoints<br /><br><br /><br>Feasibility<br /><br>Feasibility measures were operationalised by adherence rate, number of<br /><br>drop-outs and reasons for dropping out, possible injuries or complications<br /><br>during and due to the training program and the number of participants that<br /><br>completed the training program and indicated that they wanted to continue<br /><br>training. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary study parameters<br /><br><br /><br><br /><br><br /><br>Significant increase in quality of life measured by several questionnaires<br /><br>(EORTC QLQ C30, SCL-90)<br /><br><br /><br>Significante in physical fitness ( strength, endurance) after the training<br /><br>program compared to before.<br /><br><br /><br>Increase in empowerment, after the training program compared to before. (CEQ,<br /><br>remoralisation -scale )<br /><br>Significante decrease in symptoms as measured with the Distress Thermometer<br /><br>(DT) and HADS.</p><br>